Platelets play a fundamental role in normal hemostasis, while their inherited or acquired dysfunctions are involved in a variety of bleeding disorders or thrombotic events. Several laboratory methodologies or point-of-care testing methods are currently available for clinical and experimental settings. These methods describe different aspects of platelet function based on platelet aggregation, platelet adhesion, the viscoelastic properties during clot formation, the evaluation of thromboxane metabolism or certain flow cytometry techniques. Platelet aggregometry is applied in different clinical settings as monitoring response to antiplatelet therapies, the assessment of perioperative bleeding risk, the diagnosis of inherited bleeding disorders or in transfusion medicine. Platelet aggregometry testing plays a role in the diagnosis of inherited platelet function disorders in the hands of hematologists.
Platelet Aggregation Devices Market Driving Factors
- The demand within the global platelet aggregation market has been increasing on account of several key advancements of platelet systems. Several efforts have been made in the past, and the emergence of advanced aggregometry is the latest development in this domain. Hence, it is evident that the global market for platelet aggregation market would expand at a starry rate in the years to come and would also give a launch pad to the growth of the global market players.
- Expanding ageing population is one of the key drivers of the platelet aggregation devices market. With the growing in geriatric population, chronic diseases are becoming increasingly common, which will drive platelet aggregation market.
- Likewise, factors such as the rise in public awareness and the increasing research and development activities have been driving the growth of the global platelet aggregation market, and the trend is expected to continue over the forecast period.
Platelet Aggregation Devices Market Challenges
- Th platelet aggregation devices market faces certain challenges such as Procedural Limitations, Procedural Limitations
- Dearth of Well-Trained, Skilled, and Experienced Professionals is expected to hamper the global platelet aggregation devices market growth over the forecast period.
Platelet Aggregation Devices Market Segmental Highlights
The report analyses the global Platelet Aggregation Devices market based on type, wound type, end user and geography.
- In terms of types, the global platelet aggregation devices market is bifurcated into, instruments, reagents, and consumables & accessories. The platelet aggregation systems segment will observe highest demand attributed to various factors including constant advancements in the field of sensors and detectors, increasing trend of automation of platelet aggregation testing procedures, and enhanced patient acquiescence offered by point-of-care testing analyzers as linked to traditional instruments..
- The platelet aggregation devices market finds application in research and clinical applications. Clinical application consists of cardiovascular applications, orthopedic and other clinical applications such as bleeding disorders, antiplatelet therapy, and trauma. The increasing prevalence of targets disorders such as CVD’s acts as a key factor for the growth of platelet aggregation devices segment.
- North America commanded the largest share of the market in 2019, owing to factors such as rising incidence of patients suffering from chronic disorders, an increasing number of surgical procedures, increasing awareness among the healthcare professionals regarding the advantages of platelet aggregation testing..
- The demand within the hematology analyzers market in North America is expected to witness several key opportunities over the forthcoming years. It is expected that a paradigm shift would come to the fore of the regional market as better diagnostics are developed in the US and Canada.
Platelet Aggregation Devices Market Key Players
- Aggredyne Inc.
- Bio Data Corporation
- Chrono-Log Corporation
- F. Hoffmann-La Roche Ltd
- Haemonetics Corporation
- Sysmex Corporation
- Siemens AG
- Accriva Diagnostics
- Helena Laboratories Corporation
- Bio/Data Corporation
- Sentinel Ch. S.P.A.
- TEM Group
The report analyses the global Platelet Aggregation Devices market based on type, wound type, end user and geography. On the basis of products, the global platelet aggregation devices market is classified into three major segments, namely, systems, reagents, and consumables & accessories. On the basis of applications, the global platelet aggregation devices market is classified into research applications and clinical applications. The clinical applications segment is further classified into three subsegments, namely, cardiovascular, orthopedic, and other clinical applications. Geographically the global platelet aggregation market is segmented into North America, Europe, Asia Pacific, and Rest of the world.
The major players operating in the platelet aggregation devices market are Aggredyne Inc., Bio Data Corporation, Chrono-Log Corporation, F. Hoffmann-La Roche Ltd, Haemonetics Corporation, Sysmex Corporation, Siemens AG, Accriva Diagnostics, Helena Laboratories Corporation, Bio/Data Corporation, Sentinel Ch. S.P.A. and TEM Group among others
Why to buy this report:
- The report offers changing market dynamics in the platelet aggregation devices market, presenting historical, current and projected market size in terms of value (USD Million)
- The research study provides an in-depth analysis of the industry value chain focusing on the peer and parent markets of platelet aggregation devices market
- It presents a comprehensive assessment of geographical regions exhibiting promising growth, potential and niche segments, and a neutral perspective on the platelet aggregation devices market performance
- The report also offers strategic recommendations in key business segments based on the market estimations and competitive landscape, mapping the key common trends of platelet aggregation devices market
